News Pieris Pharmaceuticals, Inc.

Equities

PIRS

US7207951036

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-16 pm EDT			5-day change	1st Jan Change
0.164 ^USD	-3.53%		-9.79%	-9.89%

Apr. 03	North American Morning Briefing : Powell Awaited -2-	DJ
Mar. 29	Pieris Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

North American Morning Briefing : Powell Awaited -2-	Apr. 03	DJ
Pieris Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 29	CI
Pieris Pharmaceuticals Announces Strategy to Maximize Partnered Milestone and Royalty Potential	Mar. 28	AQ
Pieris Pharmaceuticals : Announces Strategy to Maximize Partnered Milestone and Royalty Potential - Form 8-K	Mar. 27	PU
North American Morning Briefing : Stocks Edge -2-	Mar. 27	DJ
Prime Medicine Names Foghorn Therapeutics' CFO to be its New Finance Chief	Jan. 05	MT
North American Morning Briefing : Stocks Seen -2-	Nov. 15	DJ
Pieris Pharmaceuticals: Q3 Earnings Snapshot	Nov. 14	AQ
Pieris Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
North American Morning Briefing : Stock Futures -2-	Nov. 08	DJ
Pieris Pharmaceuticals, Inc.(NasdaqCM:PIRS) dropped from S&P Global BMI Index	23-09-18	CI
Vicore Pharma's New CEO to Formally Take Office	23-09-08	MT
Dr. Hitto Kaufmann appointed Chief Scientific Officer of Hansa Biopharma	23-09-04	AQ
Sweden’s Hansa Biopharma Appoints New Chief Scientific Officer	23-09-01	MT
Dr. Hitto Kaufmann appointed Chief Scientific Officer of Hansa Biopharma	23-09-01	AQ
Pieris Pharmaceuticals Announces Milestone Achievement for Boston Pharmaceuticals Initiation of Phase 1/2 Study of BOS-342, a 4-1BB/GPC3 Immuno-Oncology Bispecific	23-08-18	AQ
Pieris Pharmaceuticals Says Patient Dosing in Cancer Drug Trial Triggers Milestone Payment From Boston Pharmaceuticals	23-08-17	MT
North American Morning Briefing : Treasury Yields -2-	23-08-17	DJ
Pieris Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
North American Morning Briefing : Attention Turns -2-	23-08-10	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Pieris Pharmaceuticals, Inc.

Equities

PIRS

US7207951036

Summary

Filters